Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Among patients with chronic kidney disease, use of in-person services was dramatically reduced during the early months of COVID-19 pandemic, which was followed by an incomplete rebound, according to presented data.
“Telehealth helped, but it only partially compensated for the reduction that we saw in utilization,”
Clarissa Jonas Diamantidis, MD, MHS, said during her presentation at the National Kidney Foundation Spring Clinical Meetings, which was held as a virtual event. Source: Adobe Stock
email article
The COVID-19 pandemic led to a stark decline in kidney care that has yet to rebound, a new retrospective study suggested.
Overall healthcare utilization dropped by 43% during the pandemic among Medicare beneficiaries with advanced chronic kidney disease (CKD) compared with the year prior, reported Clarissa Diamantidis, MD, MHS, of Duke University School of Medicine in Durham, North Carolina, and colleagues.
Based on healthcare utilization prior to the pandemic specifically January 2019 through February 2020 these CKD patients were expected to have roughly 2.74 million in-person healthcare visits during the period in which the pandemic hit. But from March through June 2020, this group only actually had about 1.56 million in-person healthcare visits.